238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.75%
Some net income increase while META is negative at -15.35%. John Neff would see a short-term edge over the struggling competitor.
-26.09%
Negative yoy D&A while META is 5.85%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-34.13%
Negative yoy deferred tax while META stands at 210.88%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
16.20%
SBC growth well above META's 2.58%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-172.44%
Both reduce yoy usage, with META at -175.73%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
151.31%
AR growth well above META's 127.75%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-175.75%
Both reduce yoy inventory, with META at -177.25%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-201.97%
Both negative yoy AP, with META at -346.43%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-2.64%
Both reduce yoy usage, with META at -177.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-74.43%
Both negative yoy, with META at -206.45%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-14.94%
Both yoy CFO lines are negative, with META at -12.81%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-8.45%
Negative yoy CapEx while META is 7.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-350.27%
Negative yoy acquisition while META stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-0.32%
Both yoy lines negative, with META at -8.61%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
10.36%
Proceeds from sales/maturities above 1.5x META's 6.89%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
152.63%
Growth well above META's 92.59%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
26.07%
Investing outflow well above META's 5.78%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-1543.86%
We cut debt repayment yoy while META is 26.34%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-44.17%
Both yoy lines negative, with META at -104.20%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.